Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dräger Award for Intensive Care Medicine bestowed

02.06.2008
At this year's Congress of the European Society of Anaesthesiology (ESA), Euroanaesthesia 2008, in Copenhagen, the ESA presented the “Dräger Award for Intensive Care Medicine”. The 10,000 Euro endowment was donated by Dräger.

The award went to the working group studying “Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis” in the Department of Anesthesiology, Rigshospitalet, at the Juliane Marie Centre and Copenhagen Trial Unit, University of Copenhagen, Denmark.


During the opening ceremony, Professor Jennifer M Hunter, Chairperson of the ESA Scientific Programme Committee, together with Dr Markus Keussen, Head of Dräger Strategic Business Field Anesthesiology, presented the award to Dr Arash Afshari, representing this working group.

The prize
This annual prize honors significant European research in the field of intensive care medicine published in peer-reviewed intensive care or anesthesiology journals in the preceding year. The prize is given to the anesthetic or intensive care department that produces the article rather than any one research worker.

This year, the Dräger Prize subcommittee of the ESA who judged the prize recognized this working group for their systematic, detailed and methodical approach in a large meta-analysis of the effects of anti-thrombin III in critically ill patients.

With this prize, Dräger wishes to honor scientific endeavors and support advances in the field of critical care medicine.

The award recipients
Dr Afshari’s working group has brought together all the published papers on the role of one of the body’s anti-clotting proteins (which also has anti-inflammatory properties), anti-thrombin III, to study its benefits or harm when it is given to critically ill patients. Data from 3458 patients was available suggesting that this clotting product was not suitable to give to intensive care patients despite its anti-inflammatory effects: the risk of excessive bleeding was too great.

As Chairman of the Dräger Prize Subcommittee, Prof Jennifer M. Hunter MB ChB PhD FRCA, School of Clinical Science (Anaesthesia), University of Liverpool, UK, stated that this paper was selected as it showed the highest standard of scientific study of all the submissions, with results that were most likely to affect future clinical practice.

About Dräger
Drägerwerk AG & Co. KGaA is an international leader in the fields of medical and safety technology: Dräger products protect, support and save human life. Founded in 1889, in 2007 the Group achieved sales of 1,819.5 million Euro worldwide and an EBIT of 151.9 million Euro. Today, Dräger employs around 10,000 people in more than 70 subsidiaries worldwide and has representation in around 190 countries. The Dräger Medical subsidiary offers products, services and integrated system solutions which accompany the patient throughout the care process - Emergency Care, Perioperative Care, Critical Care, Perinatal Care and Home Mechanical Ventilation.
1) Head of the working group: Dr Arash Afshari; members: Dr Jorn Wetterslev,
Dr Jesper Brok, Dr Ann Moller, all of the Rigshospitalet, at the Juliane Marie Centre the Copenhagen Trial Unit and the Cochrane Anaesthesia Review Group, University of Copenhagen, Denmark.

2) BMJ 2007; 335: 1248-51
Contact for Trade Press:
Birgit Diekmann
Tel.: +49 451 882 1215
E-mail: birgit.diekmann@draeger.com

Birgit Diekmann | Drägerwerk AG & Co. KGaA
Further information:
http://www.draeger.com

More articles from Awards Funding:

nachricht Innovation Award of the United Nations Environment Programme for PhD Student from ZMT
22.03.2018 | Leibniz-Zentrum für Marine Tropenforschung (ZMT)

nachricht ERC Project set to boost application of adhesive structures
19.03.2018 | INM - Leibniz-Institut für Neue Materialien gGmbH

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>